Therapeutic drug monitoring in older adults treated with beta-lactams or daptomycin in a French tertiary hospital: A retrospective study (TEldBet) - 22/07/26
, Achille Tchalla a, bHighlights |
• | One of the few studies focussing on therapeutic drug monitoring (TDM) in older adult patients receiving high-dose antibiotic therapy. |
• | The population was representative of hospitalized geriatric patients, with numerous comorbidities. |
• | TDM remains underused in current practice, despite the vulnerability of this population to both over- and under-dosing. Only a minority of patients achieve the target concentration. |
• | TDM could reduce hospital deaths and side effects in older patients treated with high doses of beta-lactams or daptomycin. |
• | High-dose beta-lactams or daptomycin entail a substantial risk of adverse events in older adults. |
Abstract |
Introduction |
Predispositions such as immunosenescence expose older adults to infections. Aging and sepsis lead to pharmacokinetic modifications, especially in antibiotic treatments. For severe infections such as infective endocarditis or bacteraemia, high doses of antibiotics are needed, frequently beta-lactams. Due to pharmacokinetic changes, older adults are at risk of overexposure or underexposure. The first can lead to adverse events and the second to longer length of stay or treatment failure, both of which lead to functional decline.
Methods |
A retrospective single-centre study. Aged ≥ 75 years, the included patients suffered from a bacterial infection requiring high-dose intravenous beta-lactams or daptomycin.
The primary endpoint was the proportion of patients having undergone serum concentration measurement. Secondary endpoints included the clinical and biological characteristics associated with serum concentration monitoring, the clinical and biological factors associated with the likelihood of monitoring, and outcomes related to whether or not serum concentration measurement was performed.
Results |
One hundred and fifty-two (152) patients were included. The proportion of patients having undergone serum concentration measurement was 40.1% (61). The median age was 80 ± 9 years. The median Charlson Comorbidity Index score was 8 ± 4.
Patients having undergone serum concentration monitoring had significantly higher rates of bacteraemia and endocarditis.
Patients with Therapeutic Drug Monitoring (TDM) were found to experience fewer adverse events (39.3%, 95% CI: 27.1–52.7 vs. 45.1%, 95% CI: 34.6–55.8; p = 0.414) and lower in-hospital mortality (13.1%, 95% CI: 5.8–24.2 vs. 17.6%, 95% CI: 10.4–27.0; p = 0.459).
Conclusion |
While TDM could help to optimize treatment of older adults with infections, it remains underused. Further studies are needed to confirm its usefulness in the management of severe infections.
Le texte complet de cet article est disponible en PDF.Keywords : TDM, Antibiotics, Beta-lactams, Older adults
Plan
Vol 56 - N° 5
Article 105286- juillet 2026 Retour au numéro
Article précédent
- Central nervous system tuberculosis in Tunisia: clinical phenotypes from a 14-year cohort
- Khalil Tritar, Rajah Rezgui, Imen Beji, Olfa Smaoui, Houda Limam, Fatma Gassara, Lamia Ammari, Rim Abdelmalek
- Impact of discontinuing antibiotic susceptibility testing for Enterococcus faecalis-positive urine cultures on antibiotic prescriptions
- Guillaume Baronnet, Elodie Jeanbert, Emeric Emond, Philippe Cailloux, Nejla Aïssa, Nathalie Thilly, Maïa Simon, Alexandre Charmillon
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?